Reach out to request a demo or to partner with us.
At Streamline Bio, we believe that innovation starts with people. Our team brings together experts in AI, robotics, and advanced therapy manufacturing—united by a shared mission to transform how cell and gene therapies reach patients.
We work side-by-side with our partners, combining deep technical expertise with a collaborative mindset to build solutions that scale science and save lives.
Yu-Shun (Leo) Hsiao, PhD, is the Founder and CEO of Streamline Bio, an AI-driven robotics company building an autonomous platform for end-to-end cell and gene therapy manufacturing — designed to integrate with existing infrastructure, devices, and compliance systems to reduce manual intervention, improve process consistency, and expand patient access to next-generation therapies.
A Harvard-trained computer scientist, Dr. Hsiao's doctoral and NVIDIA research focused on safety-aware system optimization for autonomous robots, spanning machine perception, motion planning, and hardware–software co-design. He holds a PhD in Computer Science from Harvard University and a BSc from National Tsing Hua University, Taiwan.
Please fill out the form and we’ll get back to you. You can also email us directly at [email protected].